BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 28671110)

  • 1. Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer's Disease.
    Bellanti F; Iannelli G; Blonda M; Tamborra R; Villani R; Romano A; Calcagnini S; Mazzoccoli G; Vinciguerra M; Gaetani S; Giudetti AM; Vendemiale G; Cassano T; Serviddio G
    J Alzheimers Dis; 2017; 59(2):615-631. PubMed ID: 28671110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulated clock gene expression and abnormal diurnal regulation of hippocampal inhibitory transmission and spatial memory in amyloid precursor protein transgenic mice.
    Fusilier AR; Davis JA; Paul JR; Yates SD; McMeekin LJ; Goode LK; Mokashi MV; Remiszewski N; van Groen T; Cowell RM; McMahon LL; Roberson ED; Gamble KL
    Neurobiol Dis; 2021 Oct; 158():105454. PubMed ID: 34333153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal circadian locomotor rhythms and Per gene expression in six-month-old triple transgenic mice model of Alzheimer's disease.
    Wu M; Zhou F; Cao X; Yang J; Bai Y; Yan X; Cao J; Qi J
    Neurosci Lett; 2018 May; 676():13-18. PubMed ID: 29626648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degeneration and energy shortage in the suprachiasmatic nucleus underlies the circadian rhythm disturbance in ApoE
    Zhou L; Gao Q; Nie M; Gu JL; Hao W; Wang L; Cao JM
    Sci Rep; 2016 Nov; 6():36335. PubMed ID: 27824104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer's disease.
    Duncan MJ; Smith JT; Franklin KM; Beckett TL; Murphy MP; St Clair DK; Donohue KD; Striz M; O'Hara BF
    Exp Neurol; 2012 Aug; 236(2):249-58. PubMed ID: 22634208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal Clock Gene Expression and Locomotor Activity Rhythms in Two Month-Old Female APPSwe/PS1dE9 Mice.
    Oyegbami O; Collins HM; Pardon MC; Ebling FJP; Heery DM; Moran PM
    Curr Alzheimer Res; 2017; 14(8):850-860. PubMed ID: 28317486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1. Circadian changes.
    Sterniczuk R; Dyck RH; Laferla FM; Antle MC
    Brain Res; 2010 Aug; 1348():139-48. PubMed ID: 20471965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Targeting of Casein Kinase 1δ/ε in an Alzheimer's Disease Mouse Model.
    Adler P; Mayne J; Walker K; Ning Z; Figeys D
    J Proteome Res; 2019 Sep; 18(9):3383-3393. PubMed ID: 31334659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease.
    Bedse G; Romano A; Cianci S; Lavecchia AM; Lorenzo P; Elphick MR; Laferla FM; Vendemiale G; Grillo C; Altieri F; Cassano T; Gaetani S
    J Alzheimers Dis; 2014; 40(3):701-12. PubMed ID: 24496074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orexin signaling regulates both the hippocampal clock and the circadian oscillation of Alzheimer's disease-risk genes.
    Ma Z; Jiang W; Zhang EE
    Sci Rep; 2016 Oct; 6():36035. PubMed ID: 27796320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered cellular redox status, sirtuin abundance and clock gene expression in a mouse model of developmentally primed NASH.
    Bruce KD; Szczepankiewicz D; Sihota KK; Ravindraanandan M; Thomas H; Lillycrop KA; Burdge GC; Hanson MA; Byrne CD; Cagampang FR
    Biochim Biophys Acta; 2016 Jul; 1861(7):584-93. PubMed ID: 27040510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease.
    Romano A; Pace L; Tempesta B; Lavecchia AM; Macheda T; Bedse G; Petrella A; Cifani C; Serviddio G; Vendemiale G; Gaetani S; Cassano T
    Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25609597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental enrichment lessens cognitive decline in APP23 mice without affecting brain sirtuin expression.
    Polito L; Chierchia A; Tunesi M; Bouybayoune I; Kehoe PG; Albani D; Forloni G
    J Alzheimers Dis; 2014; 42(3):851-64. PubMed ID: 24961946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent increment of hydroxymethylation in the brain cortex in the triple-transgenic mouse model of Alzheimer's disease.
    Cadena-del-Castillo C; Valdes-Quezada C; Carmona-Aldana F; Arias C; Bermúdez-Rattoni F; Recillas-Targa F
    J Alzheimers Dis; 2014; 41(3):845-54. PubMed ID: 24685633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Casein kinase I epsilon gene transfer into the suprachiasmatic nucleus via electroporation lengthens circadian periods of tau mutant hamsters.
    Wang H; Ko CH; Koletar MM; Ralph MR; Yeomans J
    Eur J Neurosci; 2007 Jun; 25(11):3359-66. PubMed ID: 17553004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.
    Morin JP; Cerón-Solano G; Velázquez-Campos G; Pacheco-López G; Bermúdez-Rattoni F; Díaz-Cintra S
    J Alzheimers Dis; 2016; 51(1):69-79. PubMed ID: 26836189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of normal circadian clock function in a mouse model of tauopathy.
    Stevanovic K; Yunus A; Joly-Amado A; Gordon M; Morgan D; Gulick D; Gamsby J
    Exp Neurol; 2017 Aug; 294():58-67. PubMed ID: 28461004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disturbed circadian rhythm and retinal degeneration in a mouse model of Alzheimer's disease.
    Carrero L; Antequera D; Alcalde I; Megías D; Figueiro-Silva J; Merayo-Lloves J; Municio C; Carro E
    Acta Neuropathol Commun; 2023 Mar; 11(1):55. PubMed ID: 37004084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.